Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University of Oxford.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
BioMarin Pharmaceutical
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00423280
First received: January 17, 2007
Last updated: August 6, 2008
Last verified: June 2008